Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Tie

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
BMJ Open Gastroenterology|February 23, 2024
Efficacy of TIPS plus extrahepatic collateral embolisation in real-world data: a validation studyLianhui Zhao, Jun Tie, Guangchuan Wang, et al.
Gut|May 29, 2015
POU2F2-oriented network promotes human gastric cancer metastasisSi-Meng Wang, Jun Tie, Wen-Lan Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2024
Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort StudyYifu Xia, Jun Tie, Guangchuan Wang, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2025
Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicenter Real-World StudyYi Xiang, Jun Tie, Guangchuan Wang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 2, 2018
Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosisChuangye He, Yong Lv, Zhengyu Wang, et al.
Investigational New Drugs|July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCCEnxin Wang, Dongdong Xia, Wei Bai, et al.
European Radiology Experimental|June 16, 2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.
Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.
Nature Communications|March 27, 2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
BMJ Open Gastroenterology|February 23, 2024
Efficacy of TIPS plus extrahepatic collateral embolisation in real-world data: a validation studyLianhui Zhao, Jun Tie, Guangchuan Wang, et al.
Gut|May 29, 2015
POU2F2-oriented network promotes human gastric cancer metastasisSi-Meng Wang, Jun Tie, Wen-Lan Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2024
Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort StudyYifu Xia, Jun Tie, Guangchuan Wang, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2025
Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicenter Real-World StudyYi Xiang, Jun Tie, Guangchuan Wang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 2, 2018
Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosisChuangye He, Yong Lv, Zhengyu Wang, et al.
Investigational New Drugs|July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCCEnxin Wang, Dongdong Xia, Wei Bai, et al.
European Radiology Experimental|June 16, 2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.
Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.
Nature Communications|March 27, 2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancerEmily Golden, Rabab Rashwan, Eleanor A Woodward, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Pageof 8